Multiple Sclerosis News

May 22, 2015May 22, 2015

Researchers Identify Potential Cause of Multiple Sclerosis Movement, Balance Problems

Multiple Sclerosis News, News

Researchers in the Department of Immunology at St. Jude Children’s Research Hospital in Memphis were able to identify a faulty “brake” in immune cells which may be involved in the inflammation ... Read more

May 21, 2015October 21, 2015

11-Year Follow-up of Bayer’s BENEFIT Interferon-beta1b Treatment Reveals Positive Results For MS Patients

Multiple Sclerosis News, News

Results from the BENEFIT11 trial indicate that early treatment with IFNB-1b leads to improvements in cognition and fatigue in the long-term, as well as sustained employment and favorable magnetic resonance imaging ... Read more

May 20, 2015May 20, 2015

Genzyme Announces New Research Collaboration With Ablynx for Innovative Multiple Sclerosis Therapeutic Project

Multiple Sclerosis News, News

This week, Belgian-based biopharmaceutical company Ablynx announced they have entered into an exclusive research collaboration with Genzyme, a Sanofi company, to investigate the use of Nanobodies as part of ... Read more

May 20, 2015May 20, 2015

International Multiple Sclerosis Conference to Focus on Patients’ Experience

Multiple Sclerosis News, News

The 4th International MS Patient Summit, which will be held on May 22 in Rome, Italy, will explore feedback from patients who suffer from multiple sclerosis (MS) in an effort to increase knowledge ... Read more

May 19, 2015May 19, 2015

Case Study Explores Hypnosis as Potential Treatment For Multiple Sclerosis Symptoms

Multiple Sclerosis News, News

Two Dragons Hypnotherapy recently announced the results of a one-year case study that assessed the effects of hypnotherapy on a patient with multiple sclerosis (MS) named Kristen. Case studies such ... Read more

May 18, 2015May 18, 2015

New Genetic Variant as Predictor of Patients’ Response to MS Treatment

Multiple Sclerosis News, News

A team led by researchers at San Raffaele Scientific Institute in Italy and Brigham and Women’s Hospital in Boston, Massachusetts recently revealed a new genetic variant linked to multiple sclerosis ... Read more

May 18, 2015

MSAA Organizes Make a Splash Fundraising Event for Memorial Day

Multiple Sclerosis News, News

The Multiple Sclerosis Association of America (MSAA) is organizing a national fundraising campaign just in time for summer. The Swim for MS event will help the association fund activities and support the multiple sclerosis ... Read more

May 18, 2015May 25, 2015

Gut Bacteria: Key to MS?

Multiple Sclerosis News, News

There has been a great deal of recent interest in the connection between nervous system function and the complex bacteria that are found in the gastrointestinal system, known as ... Read more

May 15, 2015May 15, 2015

Yale and MIT Researchers Discover a Key Immune Difference in Multiple Sclerosis Patients

Multiple Sclerosis News, News

A new study recently published in the journal Science Translational Medicine revealed a key difference in immune T cells between multiple sclerosis (MS) patients and healthy individuals. The study ... Read more

May 15, 2015May 15, 2015

Singer Releases Song About MS Recovery After Receiving Stem Cell Therapy

Multiple Sclerosis News, News

Singer Kristen King began to experience fatigue, muscle weakness and later paralysis in some parts of the body in 2013, and it came as a shock when she was diagnosed ... Read more

May 14, 2015May 14, 2015

Celiac Disease Found to Be Linked to Increased Risk of Multiple Sclerosis, Nerve Damage

Multiple Sclerosis News, News

A study recently published in the journal JAMA Neurology revealed that celiac disease is linked to a significant increase in the risk of nerve damage. The study is entitled ... Read more

May 14, 2015May 14, 2015

PA Hospital Begins Offering LEMTRADA as Treatment for Relapsing Multiple Sclerosis

Multiple Sclerosis News, News

The Allegheny General Hospital in Pennsylvania is now offering a new treatment option for people with relapsing remitting multiple sclerosis (RRMS) — the most common form of multiple sclerosis.  The treatment ... Read more

May 13, 2015May 22, 2015

Major Progressive MS Trial Completes Enrollment For Experimental Therapy

Multiple Sclerosis News, News

While multiple sclerosis (MS) is considered a rare condition with major unmet medical needs, the treatments for progressive forms of MS are even scarcer, with no viable, FDA-approved drugs available to specifically ... Read more

May 12, 2015May 12, 2015

Amarantus Releases Preliminary Data From Blood-Based MS Diagnostic

Multiple Sclerosis News, News

Amarantus BioScience has released preliminary data from a blood test for multiple sclerosis (MS) called the MSPrecise diagnostic. The company believes that the test could lead to more accurate diagnoses of MS early ... Read more

May 12, 2015May 12, 2015

Researchers Identify Drugs That Promote Remyelination in Mice

Multiple Sclerosis News, News

In a recent publication in Nature, titled “Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo” a team of researchers from Case Western University and Northwestern University screened a ... Read more

May 11, 2015May 11, 2015

Problem Drinking in MS Associated with Anxiety and Family History

Multiple Sclerosis News, News

Multiple sclerosis (MS) presents many life-altering challenges, but most patients naturally focus most often on the physical challenges associated with the condition: problems with movement, sensation and vision that occur as ... Read more

May 11, 2015May 11, 2015

Oral Drugs May Reduce Preference for Injectable Drugs in Multiple Sclerosis Treatment

Multiple Sclerosis News, News

Frost & Sullivan recently published a report entitled “A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market” providing insight into the global multiple sclerosis (MS) drug market. In this ... Read more

May 8, 2015May 8, 2015

Student Changes Life Plans to Help Others with MS

Multiple Sclerosis News, News

Just like any student, Stephanie Butler was excited to start working, in her case as a nurse, when she began experiencing numbness in her limbs and lost sensation below the waist. ... Read more

May 8, 2015June 11, 2015

MediciNova Completes Enrollment for Phase 2b Study of Experimental Progressive Multiple Sclerosis Treatment

Multiple Sclerosis News, News

MediciNova, Inc., a publicly-traded biopharmaceutical company developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs, recently announced that the National Institute of Neurological Disorders and ... Read more

May 7, 2015May 7, 2015

Myelin Repair Foundation and NIH to Study Guanabenz for MS

Multiple Sclerosis News, News

The Myelin Repair Foundation (MRF) and National Institutes of Health (NIH) will initiate a clinical trial of guanabenz in people with multiple sclerosis (MS). Guanabenz is FDA-approved for high blood pressure, but ... Read more

May 5, 2015May 5, 2015

Promising New Therapy for Multiple Sclerosis Based on Placenta Cells

Multiple Sclerosis News, News

A study published in the journal Multiple Sclerosis and Related Disorders, led by researchers at Mount Sinai in New York and Celgene Cellular Therapeutics revealed that an infusion based on cells ... Read more

May 4, 2015June 26, 2015

EXCLUSIVE: Opexa Developing Tcelna as a True Personalized MS Therapy For SPMS, RRMS

Multiple Sclerosis News, News

After the Phase 2b clinical trial named Abili-T achieved full enrollment with 190 secondary progress multiple sclerosis (SPMS) patients, The Woodlands, Texas-based Opexa Therapeutics is patiently awaiting results for the ... Read more

May 1, 2015May 1, 2015

Genzyme’s LEMTRADA Maintain’s Effectiveness in Reducing Brain Atrophy According to Recent Study Results

Multiple Sclerosis News, News

Genzyme presented new magnetic resonance imaging (MRI) data from the Lemtrada® (alemtuzumab) clinical development program on April 23, 2015, at the 67th American Academy of Neurology (AAN) Annual Meeting. The company showed that ... Read more

April 30, 2015May 1, 2015

Study Outlines Alarming Inflation Of MS Drug Costs Over Past Two Decades

Multiple Sclerosis News, News

Researchers at Oregon Health & Science University (OHSU) College of Pharmacy and Oregon State University (OSU) at Corvallis, and Veterans Affairs Medical Center in Portland, Oregon, have documented an ... Read more

April 30, 2015April 30, 2015

MS Society To Invest £2 million in Edinburgh Centre for Multiple Sclerosis Research

Multiple Sclerosis News, News

The MS Society recently announced it will invest £2 million into the Edinburgh Centre for MS Research. This funding will support the research work of a team of about fifteen world-leading ... Read more

April 29, 2015April 29, 2015

Preliminary Results For MS Stem Cell Trial Reveals Safety, Tolerability in Test Subjects

Multiple Sclerosis News, News

Tisch MS Research Center of New York (Tisch MSRCNY) researchers presented preliminary results from an FDA-approved Phase I trial, a small-scale investigation in humans using autologous neural stem cells for ... Read more

April 29, 2015April 29, 2015

Can Suppressing a Protein Associated With Good Health Help Treat MS?

Multiple Sclerosis News, News

Gladstone Institutes scientists have discovered a successful new treatment that could potentially be used in multiple sclerosis (MS). The treatment involves suppressing a protein that traditionally is associated with overall ... Read more

April 28, 2015July 19, 2016

MS Views and News to Host Educational Patient Programs in May

Multiple Sclerosis News, News

MS Views and News (MSVN), a non-profit organization focused on collecting and distributing information about multiple sclerosis (MS), is hosting a series of educational patient programs and events during the month ... Read more

April 28, 2015May 22, 2015

Researchers, Biotech Companies Present Key MS Discoveries & Therapy Updates at Recent Conference

Multiple Sclerosis News, News

The 67th American Academy of Neurology Annual Meeting took place last week in Washington, DC and included eight investigators from the Tisch MS Research Center of New York, whose research efforts ... Read more

April 27, 2015April 27, 2015

FDA Accepts Bayer’s BETACONNECT License Application for Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis News, News

Bayer HealthCare recently announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of a supplemental Biologics License Application (sBLA) for BETACONNECT for the treatment of relapsing-remitting multiple ... Read more

April 27, 2015April 27, 2015

Study Tests Safety & Efficacy of New Treatment Intervals For MS Therapy Natalizumab

Multiple Sclerosis News, News

A new study presented last week during the American Academy of Neurology’s 67th Annual Meeting in Washington, DC provides new treatment strategies for multiple sclerosis (MS) using a monoclonal ... Read more

April 24, 2015October 20, 2015

Actelion to Accelerate Clinical Trials For Experimental Therapy That Treats MS, Other Autoimmune Diseases

Multiple Sclerosis News, News

Actelion Pharma recently announced that it will accelerate the launch of clinical trials involving its lead drug candidate ponesimod, an oral, selective sphingosine-1-phosphate (S1P1). This decision came after a group of ... Read more

April 23, 2015April 23, 2015

NYU Langone Researchers Report What Happens When Multiple Sclerosis Patients Abandon Treatment

Multiple Sclerosis News, News

A team led by researchers at the New York University (NYU) Langone Medical Center recently assessed what happens when clinically stable patients with multiple sclerosis (MS) stop taking their ... Read more

April 23, 2015April 23, 2015

Phase III Study of Experimental MS Therapy Meets Primary Endpoint, Results to be Presented at ANN Meeting

Multiple Sclerosis News, News

MedDay, a French biotechnology company that studies treatments for nervous system disorders, including multiple sclerosis, announced that MD1003, a highly-concentrated biotin, is effective for treatment of progressive multiple sclerosis, according ... Read more

April 22, 2015April 22, 2015

CorTechs Labs And Novartis Partner On Solutions for Quantifying Brain Volume In MS Patients

Multiple Sclerosis News, News

San Diego based medical software developer CorTechs Labs announced that it has entered into a partnership agreement with multinational pharmaceutical maker Novartis Pharma AG. The two companies will collaborate in ... Read more

April 22, 2015April 22, 2015

MS Experts Join New Medical Advisory Board at MS Views & News

Multiple Sclerosis News, News

The non-profit organization MS Views and News (MSVN) has invited two health care experts on multiple sclerosis (MS) to join their new medical advisory board. Brian Steingo, MD and Patricia Pagnotta, MSN, ... Read more

April 22, 2015April 22, 2015

Biogen To Present Data On The Effectiveness of TECFIDERA In Newly-Diagnosed MS Patients During The ANN Annual Meeting

Multiple Sclerosis News, News

Biogen has recently announced novel results to support the effectiveness of TECFIDERA (dimethyl fumarate) in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS). The results revealed that TECFIDERA significantly reduced disability progression and relapses ... Read more

April 22, 2015April 22, 2015

Two Already-Approved Medications Could Treat MS

Multiple Sclerosis News, News

Two already available medications could be used to treat multiple sclerosis (MS). In a new study titled, “Drug Based Modulation of Endogenous Stem Cells,” published in the journal Nature on April 20, 2015, ... Read more

April 22, 2015July 19, 2016

Two Researchers Investigate FACETS Program to Fight Fatigue in MS

Multiple Sclerosis News, News

Throughout the years, Dr. Sarah Thomas and Dr. Peter Thomas at Bournemouth University have been developing a program to aid multiple sclerosis patients affected by fatigue. Their program, developed ... Read more

April 22, 2015April 22, 2015

Epilepsy Drug May Treat Eye Complications in Patients With MS

Multiple Sclerosis News, News

A new study to be presented during the American Academy of Neurology’s 67th Annual Meeting, April 24, in Washington, DC, explores the use of phenytoin, a drug commonly used to treat ... Read more